Concepedia

Mingshan Yang

MY

Statistics

Publications

6

Citations

178

H-Index

6

Active since

2013

Affiliations

Shandong Tumor Hospital(Current)

Shandong First Medical University

Zoucheng People's Hospital

Qilu Hospital of Shandong University

Mingshan Yang is an author at Shandong Tumor Hospital specializing in oncology, molecular oncology, and medicine.

Publications per year

2013–2021

6

Publications

6

Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer

Yanliang Li, Yongsheng Gao, Yue Xu et al. · Growth Factors · 2015 · 53 citations

, , +5

LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma

Renbo Guo, Benkui Zou, Yiran Liang et al. · Cell Death and Disease · 2021 · 51 citations · Full text

, , +17

The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma

Baoyong Sun, Mingshan Yang, Li Min · Biomedicine & Pharmacotherapy · 2015 · 27 citations

, , +16

Retracted: si‐<scp>RNA</scp>‐Mediated Knockdown of <scp>PDLIM</scp>5 Suppresses Gastric Cancer Cell Proliferation <i>in Vitro</i>

Yan-Liang Li, Yongsheng Gao, Yue Xu et al. · Chemical Biology & Drug Design · 2014 · 17 citations

, , +17

Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China

Benkui Zou, Zengchi Han, Zhendan Wang et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 15 citations · Full text

, , +15

1–5 of 6